Not Yet RecruitingN/Aketamine

Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Postoperative Sore Throat

Sponsored by Sohag University

NCT ID
NCT07381036
Target Enrollment
150 participants
Start Date
2026-02-01
Est. Completion
2026-09-01

About This Study

The aim of this study is to compare the efficacy of nebulized ketamine versus nebulized magnesium sulfate in reducing the incidence and severity of POST. * Primary outcome • To compare the incidence of POST method. * Secondary outcomes * Onset, Severity, and duration of POST at 0, 2, 4, 6, 12, 24 hours postoperative. * The hemodynamics recording (HR, BP, MBP, pre and post nebulization) * Adverse Effects (e.g., sedation, cough, nausea, vomiting, ….)

Conditions Studied

Postoperative Sore Throat

Interventions

  • Ketamine nebulizer
  • Mg sulfate nebulizer
  • Placebo

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Age from 18 to 65 years old.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I-II.
* Elective surgery requiring GA with endotracheal intubation.

  \- Exclusion Criteria:
* Surgery involves the oral cavity, nasopharynx, larynx, and neck regions.
* Surgery requires prone position.
* Surgery lasted more than 3 hours.
* History of preoperative sore throat, common cold.
* Anticipated difficult airway.
* Any known allergies to study drugs.
* Recent non-steroidal anti-inflammatory drugs use.
* Pregnancy.

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Shahenda AHMED Ali, Resident
CONTACT
01153378581Shahenda_ahmed_post@med.sohag.edu.eg
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Postoperative Sore Throat | Huxley